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Ca2+-dependenceThis investigation was conducted to study the relationship between intracellular Ca2+ and activation of large
conductance Ca2+-activated K+ (BK) currents by unoprostone, the ﬁrst synthetic docosanoid. We used
HEK293 cells stably transfected with two BK channel splice variants, one sensitive to unoprostone and the
other insensitive. We examined the effects of unoprostone on channel activity in excised inside–out patches
and cell-attached patches. The half-maximal stimulation of the sensitive BK channels by Ca2+ was shifted from
3.4 ± 0.017 nM to 0.81 ± .0058 nM in the presence of 10 nM unoprostone. There was no effect on insensitive
channels even at unoprostone concentrations as high as 1000nM. Therewasnoeffect of unoprostoneon the volt-
age dependence of the BK channels. Changes in open probability and effects of Ca2+ and unoprostone were best
described by a synergistic binding model. These data would suggest that Ca2+ and unoprostone were binding to
sites close to one another on the channel protein and that unoprostone binding causes the afﬁnity of the calcium
binding site to increase. This idea is consistent with three dimensional models of the Ca2+ binding site and a pu-
tative unoprostone binding domain. Our results have important implications for the clinical use of unoprostone
to activate BK channels. Channel activation will be limited if intracellular Ca2+ is not elevated.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
The goal of this study was to determine the calcium and voltage de-
pendence of large conductance potassium channels (also known as BK,
maxi-K, slo1, KCa1.1, or KCNMA1) in the presence of unoprostone.
Unoprostone isopropyl is a synthetic docosanoid. It resembles the natu-
rally occurring docosanoid metabolites of docosahexaenoic acid (DHA).
The latter is an ω-3, polyunsaturated fatty acid abundantly located in
the neural tissues of the retina and brain [19,32]. These studies are rel-
evant to the use of unoprostone (trade name Rescula®) in glaucoma
therapy in protecting against vision loss. Primary open-angle glaucoma
is a primary cause of blindness and ocular hypertensive medication de-
lays or prevents the onset of this type of glaucoma [7]. Unoprostone
causes a reduction in intraocular pressure [19]. It has been shown that
unoprostone has direct effects on the trabecular network thereby re-
ducing intraocular pressure that would otherwise be increased by hu-
moral agents [32]. These effects were due to activation of large
conductance Ca2+ activated (BK) channels that prevented contraction
of the trabecular meshwork [32]. Unoprostone has also been suggestedivated potassium channels or
l of Medicine, Department of
15 Michael Street, Atlanta, GAto protect cone photoreceptor cells from oxidative stress and light-
irradiation-induced damage by activation of BK channels [34]. The latter
ﬁnding has triggered clinical trials in retinal diseases characterized by
photoreceptor degeneration [36].
BK channels are potassium channels characterized by their large
conductance to potassium ions (K+). As with most other voltage-
gated potassium channels, BK channels have a tetrameric structure.
Each monomer of the channel-forming alpha subunit is the product of
the KCNMA1 gene. These channels are activated (opened) by changes
in membrane electrical potential and by increases in the concentration
of intracellular calcium ion (Ca2+) [20,37]. BK channels are relatively
ubiquitous potassium channels with at least six distinct functional
types of BK-channels in the CNS alone [23]. Like many other potassium
channels, BK channels occur in different cells as many different splice
variants [13,16,28,33]. The cell-surface occurrence of different splice
variants is important because different splice variants have a different
baseline activity and different sensitivity to calcium and other regula-
tors of the channels. Altering the splice variant composition of BK chan-
nels can alter their activity and apparent sensitivity to calciumand other
regulators of activity [28,33]. For example, one BK splice variant in a pi-
tuitary cell line, GH3, is sensitive to arachidonic acid (AA), but an alter-
native BK splice variant in a sub-clone of GH3 cells, GH4-C1, is not
[9–12]. GH3 and GH4 cells contain two different BK splice variants
that differ by the presence or absence of a 27 amino acid domain near
the C-terminus of the BK-α subunit and only the splice variant contain-
ing the 27 amino acid domain is sensitive to arachidonic acid. In the
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only in the presence or absence of the 27 amino acid domain near
the C-terminus (rSlo(27) and rSlo(0)) respectively, obtained from
C. S. Park [13] to test whether the splice variants are sensitive to
unoprostone, the ﬁrst synthetic docosanoid. rSlo(27) exhibits an ex-
tremely high homology with the major BK channel α-subunit from rat
brain (accession number: Nucleotide AF135265; Protein AAD34786)
while rSlo(0) exhibits an extremely high homology to a mouse brain
splice variants (muBKα, accession number: Nucleotide L16912; Protein
AAA39746).
Unoprostone is a member of a larger class of drugs, the prostones. It
has the interesting property of potentiating the sensitivity of BK chan-
nels. Asmentioned above, unoprostone is used for treating high intraoc-
ular pressure. Whether, unoprostone can be used for other indications
involving calcium-induced cytotoxicity will depend upon whether
unoprostone can activate BK channels reliably in the target organ. As
part of determining whether this was likely, we ﬁrst needed to have
speciﬁc information about the conditions under which unoprostone ac-
tivates BK channels.
2. Methods
2.1. Drugs and chemicals
Unoprostonewas obtained from Sucampo Pharmaceuticals as 1mM
solution indimethyl sulfoxide (DMSO) anddiluted in saline to appropri-
ate concentrations. Final DMSO concentrations were less than 0.01%
and produced no effect on channel activity by itself. To ensure that
there was no vehicle effect, we matched the DMSO concentration in
the unoprostone-free salines with unoprostone-containing salines in
the excised patch experiments. In addition, any effect of vehicle could
be observed as effect of the DMSO on the activity of the BK channels
in the unoprostone insensitive splice variant, rSlo(0). For all electro-
physiological experiments, drug exposure was accomplished using aFig. 1.A schematic diagramof the two BKchannel constructs, rSlo(27) and rSlo(0). A construct fo
to the truncated form to produce rSlo(0). In the second construct, bases corresponding to 27 am
In this ﬁgure the sequence between the N-terminus and 9th alpha helical domain are identica
construct and not the other. The sequence of the calcium “bowl” and the subsequent sequencegravity perfusion/suction removal technique with a perfusion rate of
2.0 ml/min and a dead volume of 1.0 ml. Previous experiments showed
that exchange was 90 ± 7% complete after 0.5 min. Cell-attached re-
cordings were used immediately. For excised patches, after obtaining
a high resistance (N25 GΩ) seal, patches were excised into a solution
with a known concentration of Ca2+ and depolarized to +40mV. Con-
trol recordings were obtained in K2EGTA buffered solutions containing
the desired Ca2+ concentration. After control recordings (typically
2–5 min), the patch was perfused with a second solution containing
the desired concentration of unoprostone and recordings continued
for an additional 10min. For experiments involving voltage dependence
measurements, 2–3 min control recordings were made at +10, +20,
+30, +40, +50, and +60 mV. The patch was then depolarized to
+40 mV and the unoprostone solution was introduced. After allowing
the effect of the prostone to stabilize (5–10 min) the voltage paradigm
described above was repeated.
2.2. Plasmids and constructs
All constructs were conﬁrmed by DNA sequencing. The rSlo con-
structs were a generous gift of C.S. Park [13]. The two constructs are
identical except for the 27 amino acid insertion or deletion near the cal-
cium binding site. A schematic diagram of the two BK constructs is
shown in Fig. 1.
2.3. Cell culture and transfection
HEK293 Maxi K α-subunit stable cell lines with either rSlo(27) or
rSlo(0) were generated in our laboratory as previously described [17]
and maintained in DMEM supplemented with 10% FCS, L-glutamine
(2mM), penicillin (100 U/ml), streptomycin (100 μg/ml), and geneticin
(1 mg/ml). All other media and components were purchased from
Invitrogen (Carlsbad, CA).rmuBKa1 (mouse)was truncated at position 953. Then the c terminus of rBKa1was added
ino acidswere added before once again adding the c terminus of rBKa1 to produce rSlo(27).
l, but the 27 amino acid region immediately prior to the calcium “bowl” is present in one
to the C-terminus are identical.
Fi
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A
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Fig. 2. The response to calcium of rSlo(0) and rSlo(27) splice variants is the same. The re-
sponse of the two splice variants to intracellular calciumwas indistinguishable in HEK293
cells which stably express rSlo(27) or rSlo(0). In excised patches depolarized to +40mV,
increasing calcium produced a statistically signiﬁcant increase in open probability for all
calcium concentrations (p b 0.5), but there is no statistically signiﬁcant difference in chan-
nel open probability between rSlo(27) and rSlo(0) at any concentration of calcium (each
bar is the mean ± s.e. of 4 separate experiments).
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Experiments in this study were carried out using either the cell-
attached or excised patch conﬁguration of the patch-clamp technique
in theHEKMaxi Kα-subunit stable cell lines. Electrodeswere fabricated
from Corning 7052 glass (Garner Glass, Fullerton, CA) in two steps on a
Narishige PP-83 electrode puller (Narishige, Tokyo, Japan). Electrodes
were ﬁre polished to a ﬁnal tip resistance between 3 and 5 MΩ.
The bath andpipette solutions used in the cell-attachedmode contained
(in mM) 140 NaCl, 1 CaCl2, 5 KCl, and 10 HEPES, pH adjusted to 7.4
with 2 N NaOH. The bath and pipette solutions used in the excised
patch mode contained (in mM) 150 KCl, 2 MgCl2, 10 N-2-
hydroxyethylpiperazine-N′-2-ethanesulfonic acid (HEPES), pH 7.30 for
the pipette and 140 KCl, 15 HEPES, 5 K2EGTA, and Ca2+ adjusted to pro-
duce various calcium activities; pH 7.4 for the bath. Recordings were
performed at room temperature. After formation of a high-resistance
(5 GΩ) seal, the channel currents were ﬁltered at 1 kHz, recorded
with an Axopatch 1-D ampliﬁer (Molecular Devices), and sampled at
5 kHz with or without ionomycin (1 μM) added to the bath solution.
Channel activity (NPo) was calculated from pClampﬁt 10.3 data-
analysis software (Molecular Devices). Channel number (N) was deter-
mined from themaximal number of transitions during 10–20min of re-
cording, and channel open probability (Po)was calculated as the ratio of
NPo to N.
2.5. Whole-cell recording
BK channel current was recorded using a whole-cell patch conﬁgu-
ration. Brieﬂy, cells on a coverslip were transferred to a cell chamber
(0.5 ml) mounted on the stage of an inverted microscope (Diaphot,
Nikon, Japan). Borosilicate glass electrodes (1.2-mm OD) were pulled
with a PP-1 puller (Narashige, Inc. East Meadow, NY) and had tip resis-
tances of 2–3 MV when ﬁlled with the pipette solution. A silver/silver
choride electrode was used as the reference electrode. The tip potential
was zeroed before patch pipette contact with the cell. After a giga-Ohm
seal was obtained by applying a negative pressure, the cell membrane
was ruptured by applying a gentle negative pressure to establish
whole cell conﬁguration. Series resistance was 3–6 MV and was com-
pensated by 80% to minimize voltage errors. The liquid junction poten-
tials were not corrected. Current signals were low-pass ﬁltered at 5 kHz
and digitized as for single channel records. All electrophysiological re-
cordingswere conducted at room temperature (22–23 °C). Extracellular
solution contained (mM) NaCl 140, KCl 5.4, MgCl2 1.0, CaCl2 1.8, 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) 10.0 (pH ad-
justed to 7.4 with NaOH). The pipette solution contained (mM) KCl
20, K-aspartate 110, MgCl2 1.0, HEPES 10, ethyleneglycoltetraacetic
acid (EGTA) 5, and various free Ca2+ activities as calculated using the
MaxChelator software [2].
2.6. Q-PCR of trabecular meshwork RNA and examination of
alternative splicing
Total RNA from Human Trabecular Meshwork Cell was obtained
from ScienCell Research Laboratories (San Diego, California, http://
sciencellonline.com/human-trabecular-meshwork-cell-total-rna.html?
_SID=U) and cDNA was synthesized using QuantiTect Reverse
Transcription kit (QIAGEN). Two sets of PCR primers speciﬁc for
Human potassium Large Conductance Calcium activated channel were
designed based on published sequences to correspond to regions
that were completely conserved in all published human sequences
and are also present in rSlo(0) and rSlo(27). The ﬁrst set of primers
ampliﬁed a region from just N-terminal to the eighth alpha helical do-
main (see Fig. 1) to a region just before the ninth alpha helical region
in the extended intracellular domain. The second set of primers ampli-
ﬁed a region that included the “calcium bowl”, the tenth alpha helicalregion, and the splice site at which 27 amino acids were inserted in
rSlo(27).rst primer set:
nse: CTACTTGGAAGGAGTCTCAAATG Antisense: GCTGAGCTGACGTCGCCA
mino acids: YLEGVSNE VVCIFGcond primer set:
nse: CATGTGCGTTATCCTGTCAGCC Antisense: GTATCAGGGTGAGGATATTGTCA
mino acids: MCVILSA DNILTLIAWe ampliﬁed (28 cycles) partial clones using Platinum Blue PCR
SuperMix (Invitrogen). The PCR products were run on a 0.8% gel. Two
bands were obtained from the ﬁrst set of primers and a single band
was obtained from the second set. DNA from each of the bands was pu-
riﬁed using QIAquick Gel Extraction Kit (QIAGEN). The products were
cloned into PCR2.1-TOPO (Invitrogen). 13 clones from the ﬁrst set of
primers and 5 clones from the second set of primers were sent for
sequencing.2.7. Statistical analysis
The data are presented as means ± SE. Statistical signiﬁcance was
determined using either a Student's t-test when two groups were com-
pared or by a one-way ANOVA, followed by Holm–Sidak's post hoc tests
when multiple groups were compared. We assigned signiﬁcance at
p b 0.05.3. Results
3.1. The response of rSlo(0) and rSlo(27) splice variants to calcium is
the same
We ﬁrst showed that the response of the two splice variants to intra-
cellular calciumwas indistinguishable in HEK293 cells which stably ex-
press rSlo(27) or rSlo(0) (Fig. 2). There is no statistically signiﬁcant
difference in channel open probability at any concentration of calcium.
Fig. 3. Response of whole cell BK currents to unoprostone. Whole cell currents in response to the voltage steps shown in panel A. Currents from HEK cells transfected with rSlo(27) inter-
nally perfused with 1 μM Ca2+ (panel B) and the same cells with 10 nM unoprostone in the bath (panel C). I–V plots from the cells that are unoprostone-treated or untreated cells are
shown for rSlo(27) (panel D) and rSlo(0) (panel E). Each point in the I–V relationships represents the mean ± s.e. of 3 separate experiments.
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We examined the effects of unoprostone on HEK293 cells which sta-
bly express rSlo(27) or rSlo(0). All the cells were spherical and of uni-
form size (13 ± 0.2 μm) as others have determined {Kaushik, 2014
21069/id}{2013 21068/id}{Dittami 21070/id}{Gentet, 2000 21067/id}.
We ﬁrst examined whole cell currents from HEK cells transfected with
rSlo(27) internally perfused with 1 μM Ca2+ (Fig. 3B) and the same
cells with 10 nM unoprostone in the bath (Fig. 3C). I–V plots fromFig. 4. Response of BK channel variants to unoprostone. In excised patches, unoprostone increas
the effect of unoprostone on open probability of the two splice variants (frommeans± s.e. of 3
and 50 nM Ca2+ in the bath, increasing concentrations of unoprostone increases open probabil
inactive (see Fig. 2) since when bath Ca2+ is increased to 500 nM (bottom trace), rSlo(0) activcells with or without unoprostone treatment or untreated cells are
shown for rSlo(27) (Fig. 3D) and rSlo(0) (Fig. 3E). Unoprostone
increased BK channels currents. We then examined the properties of
single BK channels. In excised, inside–out patches with symmetrical
140mMKCl in the bath and the pipette and 10nMCa2+ on the cytosolic
surface of the patch, unoprostone in the bath strongly activates rSlo(27)
with a half activating concentration of 4.7 ± 0.83 nM (at 10 nM Ca2+)
(Fig. 4A, C) but does not activate rSlo(0) (Fig. 4B). The activity of the
unoprostone-insensitive splice variant, rSlo(0), shows that addition ofes the open probability of rSlo(27) (panel A), but not rSlo(0) (panel B). Panel C summarizes
separate analyses of 1 min continuous recording). With the patch depolarized to+40mV
ity of rSlo(27) channels, but has little if any effect on rSlo(0). This is not because rSlo(0) is
ity is strongly increased.
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little if any effect on BK channel activity. Neither splice variant is activat-
ed by unoprostone in the patch pipette.Fig. 6. Open probability of BK channels vs calcium concentration in the presence of differ-
ent unoprostone concentrations. We examined BK channel activity in excised patches at
+60 mV with ﬁnal concentrations of calcium of 0.01, 0.1, 1, 2, 5, 10, 20, 50, 100, 500, or
1000 nM. To each of these patches we sequentially applied 0, 0.1, 0.2, 1, 2, 5, 10, 20, or
100 nMunoprostone. Theprincipal effect of unoprostone is to shift the calcium-concentra-
tion response curve to the left; i.e., unoprostone makes the channel more sensitive to cal-
cium. The half-maximal stimulation of the sensitive BK channels by Ca2+was shifted from3.3. Unoprostone does not alter the voltage dependence of BK channels
We have previously shown that the response of BK channels to lipid
modulators appears to be dependent upon both intracellular calcium
and voltage [10]; therefore, we examined the voltage dependence of
BK channels in the presence or absence of unoprostone. We examined
a range of voltages from +10 to +60 mV and 0, 1, and 10 nM
unoprostone (Fig. 5). As expected unoprostone did increase the open
probability at all potentials; however, the slopes of the open probability
vs voltage relationshipswere not signiﬁcantly different fromone anoth-
er implying that the voltage sensitivity (change in open probability per
mV) did not change. This is not surprising since contemporary under-
standing of the channel suggests that the calcium sensor and the voltage
sensor are distinct and different parts of the channel [37].3.4± 0.017nM to 0.81± .0058 nM in the presence of 10 nMunoprostone. Each point rep-
resents the mean ± s.e. of 3 separate experiments.3.4. Unoprostone shifts the calcium-dependent activation of BK channels to
lower calcium concentrations
If unoprostone does not affect the voltage dependence of channel,
then it must be altering the calcium dependence. To examine this, we
examined BK channel activity in excised patches at +60 mV with
ﬁnal concentrations of calcium of 0.01, 0.1, 1, 2, 5, 10, 20, 50, 100, 500,
or 1000 nM. To each of these patches we applied 0, 0.1, 0.2, 1, 2, 5, 10,
20, or 100 nM unoprostone. Open probability was used as a measure
of channel activity. Fig. 6 shows that the principal effect of unoprostone
is to shift the calcium-concentration response curve to the left;
i.e., unoprostone makes the channel more sensitive to calcium (Fig. 6).3.5. Unoprostone does not replace calcium
Adding unoprostone activates BK channels in the presence of calci-
um, but can it activate channels in the absence of calcium? The answer
is “no”; in the absence of calcium or at low calcium, unoprostone is inef-
fective. At high calcium, unoprostone produces little additional effect on
channel activity (Fig. 7). The relationship between unoprostone, calci-
um and BK channel activity can best be appreciated by examining a 3-
D representation of the values. Fig. 8 shows such a representation.Fig. 5. Unoprostone does not alter the voltage dependence of BK channels. Although the
open probability of BK channels is uniformly increased by unoprostone the slope of the
Po vs voltage relationship is not signiﬁcantly different in the presence of unoprostone
(44 ± 4.8, 48 ± 5.2, and 46 ± 4.6 mV per 10 fold change in Po at 10, 1, and 0 nM
unoprostones, respectively). Points are the mean ± s.e. of 3 separate experiments.3.6. Unoprostone applied to the external surface of cells activates rSlo(27)
(but not rSlo(0))
To approximate the situation during clinical application of
unoprostone, we examined the effects of unoprostone applied in the
bath outside the patch pipette in cell-attached patches; unoprostone ac-
tivates rSlo(27) channels, but not rSlo(0) (Fig. 9). Interestingly,
unoprostone in the patch pipette does not activate either splice variant.
In these cell-attached patches that probably come closer to representing
the situation during clinical administration of the drug, the half activat-
ing concentration of unoprostone on BK channels with a pipette poten-
tial of −40 mV is 13 ± 2.7 nM (Fig. 9). The question of why the half
activating dosages should be different in cell attached patches and ex-
cised patches is important to understand and has clear implications
for drug dosing and drug efﬁcacy.3.7. RNA from human trabecular meshwork cells contains a BK channel
splice variant that corresponds to rSlo(27)
We obtained total RNA from Human Trabecular Meshwork Cells
from a commercial supplier of human RNA (ScienCell ResearchFig. 7.Unoprostone does not activate BK channels in the absence of calcium.We examined
BK channel activity in excised patches at+60mVwith ﬁnal concentrations of 0, 0.1, 0.2, 1,
2, 5, 10, 20, or 100 nM unoprostone. To each of these patches we sequentially applied cal-
cium of 0.01, 0.1, 1, 2, 5, 10, 20, 50, 100, 500, or 1000 nM. At low calcium concentrations,
therewas little activation of BK channels by unoprostone imply in that the principal effect
of unoprostone was to increase calcium binding afﬁnity. Each point represents the
mean ± s.e. of 3 separate experiments.
Fig. 8. A 3-D representation of the relationship between unoprostone, calcium, and open
probability. This ﬁgure represents all the data of Figs. 6 and 7 collected together and ﬁt
with to the model given in the discussion.
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scription. Two sets of PCR primers speciﬁc for human BK channels were
designed based on published sequences (NCBI) to correspond to regions
that were completely conserved in all published human sequences andFig. 9. Unoprostone activates BK channels in cell-attached patches. The single channel record a
transfected with rSlo(27) to which sequentially larger concentrations of unoprostone are added
panded in the traces below to show individual channel events. The single channel record at the
transfectedwith rSlo(0) towhich sequentially larger concentrations of unoprostone are added.
channel events. These experiments show that under resting conditions with an intact cell, unop
To the right is the summary data showing the relationship of unoprostone concentration to BK c
When applied to the extracellular surface about 10 times as much unoprostone is necessary toare also present in rSlo(0) and rSlo(27). The ﬁrst set of primers ampli-
ﬁed a region from just N-terminal to the eighth alpha helical domain
(see Fig. 1) to a region just before the ninth alpha helical region in the
extended intracellular domain. The second set of primers ampliﬁed a re-
gion that included the “calcium bowl”, the tenth alpha helical region,
and the splice site at which 27 amino acids were inserted in rSlo(27).
We ampliﬁed partial clones with these primer pairs and the PCR prod-
ucts were run on a 0.8% gel. Two bands of similar molecular weight
were obtained from the ﬁrst set of primers and a single band was ob-
tained from the second set (Fig. 10A). After cutting out the bands and
purifying the DNA, the DNAwas cloned into PCR2.1-TOPO (Invitrogen).
13 clones from the ﬁrst set of primers and 5 clones from the second set
of primers were sent for sequencing.
All ﬁve clones from the second set of primers had the same sequence
(Fig. 10C) containing a region completely homologous to rSlo(27) im-
plying that the cells from which this RNA was derived should be sensi-
tive to unoprostone. Interestingly, 1 out of 13 clones ampliﬁed by the
ﬁrst set of primerswas a splice variant containing a 29 amino acid insert
(Fig. 10B). We are unaware of a functional signiﬁcance for this splice
variant.
4. Discussion
We have provided an extensive characterization of the responses of
BK channels to unoprostone at differentmembrane potentials and calci-
um concentrations. Unoprostone does not change the voltage sensitivi-
ty of the channels. It does however alter the apparent binding afﬁnity
for calcium without activating the channel directly. In this sense it be-
haves similarly to some other lipid modulators [8,10]. When taken all
together, the data is best ﬁt by a synergistic model in which the KMt the top is a long continuous record from a cell-attached recording from a HEK cell stably
. The patches were depolarized to +60mV. Sections of the record at A, B, C, and D are ex-
bottom is a long continuous record from a cell-attached recording from a HEK cell stably
Sections of the record at A, B, C, and D are expanded in the traces below to show individual
rostone applied extracellulary can activate rSlo(27) BK channels, but not rSlo(0) channels.
hannel open probability (Each point represents themean± s.e. of 3 separate experiments).
activate channels than in excised patches.
Fig. 10. RNA from human trabecular meshwork cells contains a BK channel splice variant that corresponds to rSlo(27). Total RNA from Human Trabecular Meshwork Cells was used to
prepare cDNA by reverse transcription. Two sets of PCR primers speciﬁc for human BK channels were designed based on published BK channel sequences (NCBI) to correspond to regions
thatwere completely conserved in all published human sequences and are also present in rSlo(0) and rSlo(27). Theﬁrst set of primers ampliﬁed a region from just N-terminal to the eighth
alpha helical domain (see Fig. 1) to a region just before the ninth alpha helical region in the extended intracellular domain. The second set of primers ampliﬁed a region that included the
“calcium bowl”, the tenth alpha helical region, and the splice site at which 27 amino acidswere inserted in rSlo(27).We ampliﬁed partial clones with these primer pairs and the PCR prod-
ucts were run on a 0.8% gel. Two bands of similarmolecular weightwere obtained from the ﬁrst set of primers and a single bandwas obtained from the second set (Fig. 10A). The DNAwas
cloned into PCR2.1-TOPO (Invitrogen). 13 clones from the ﬁrst set of amplimers and 5 clones from the second set were sequenced. All ﬁve clones from the second set of primers had the
same sequence (Fig. 10C) containing a region completely homologous to rSlo(27) implying that BK channels in the cells from which this RNA was derived should be sensitive to
unoprostone. Interestingly, 1 out of 13 clones ampliﬁed by the ﬁrst set of primers was a splice variant containing a 29 amino acid insert (Fig. 10B).
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29,35]. The model for this effect is given by the following equation:
Po ¼
Ca2þ
h i
KM
1þ Uno½ 
Ku
þ Ca2þ
h i
where Po is BK channel open probability, [Ca2+] is intracellular calcium
concentration, KM is the half-maximal activation concentration for calci-
um, [Uno] is the unoprostone concentration, and Ku is the concentration
of unoprostone that reduces the half-activating calcium concentration
by half. A least squares regression ﬁt of all the data values in Figs. 6
and 7 (lines in theﬁgures) gives a Km for calciumof 3.4±0.017 nMsim-
ilar to that described by others. The unoprostone synergism constant,
Ku, is 3.0 ± 0.24 nM. These data might suggest that Ca2+ and
unoprostone were competing for the same site on the channel protein,
but this is inconsistent with unoprostone increasing the afﬁnity for the
channel. In addition, examination of open and closed interval data
from patches containing only one channel show that unoprostone pri-
marily produces an increase in the frequency of long-lived open events
while Ca2+ reduces mean closed time suggesting that the effect of
unoprostone on BK channels may not be by a direct effect on the Ca2+
binding site. This idea is consistent with three dimensional models of
the Ca2+ binding site [37] and a putative unoprostone binding domain
consisting of the 27 amino acids inserted into rSlo(27) spatially very
close to the Ca2+ binding site.Our results also imply that unoprostone is acting directly on the
channel since it works in excised single channel patches; moreover,
unoprostone only acts from the cytosolic surface of the excised patches
consistent with the 27 amino acid insertion being close to the “calcium
bowl” on the cytosolic surface of the channel [21,24].
Unoprostone has been suggested to act as a FP receptor agonist sim-
ilar to known agonists such as PGF2α and latanoprost [15,26,27]. These
agents bind to the FP receptor and cause [Ca2+]i mobilization and stim-
ulate phosphoinositide hydrolysis [15,25]. However, the actions of
unoprostone in excised patches could not be mediated by a G protein-
linked receptor cascade. Also, even in cell-attached patches the concen-
tration of unoprostone necessary to strongly stimulate BK channels was
well below the reported EC50 values for unoprostone binding to FP re-
ceptors (5.9 μM) [19]. The highest concentration achieved in clinical
use of unoprostone, approximately 100 nM [14], is consistent with the
direct activation of BK channels we observe. It did require more
unoprostone applied to the extracellular surface to activate BK channels
in cell-attached patches. There are several potential explanations for
this difference from the activation in excised patches. Obviously, if the
intracellular calcium is particularly low, activation will be reduced;
however, most cells even in a resting state have calcium in the 10 to
100 nM rangewhich should be adequate to allow BK channel activation.
Since we depolarized the cell-attached patches, a reduced membrane
potential cannot completely explain the reduced activity in the cell-
attached patches. However, unoprostone is relatively negatively
charged. This implies that, if the cell interior is negative, that
unoprostone will partition across the membrane with less inside the
cell than outside. If the membrane were as negative as −60 mV, the
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any activation of BK channels by unoprostonewill tend to hyperpolarize
cells and thereby limit the extent of activation. We feel that this hyper-
polarization and unoprostone partitioning is sufﬁcient to explain the re-
duced activation by unoprostone in cell-attached patches.
We tested to see if the human trabecular meshwork (TBM) actually
contained a BK splice variant with the region that corresponded to the
region in our constructs that produced unoprostone sensitivity
(the rSlo(27) insert). We ampliﬁed TBM DNA and picked several clones
from the DNA products. All of the clones contained a completely homol-
ogous insert to rSlo(27). This is actually not surprising since most pa-
tients respond to unoprostone. There are 15 human splice variants of
BK channels in theNCBI database. Four of themhave the rSlo(27) insert.
When we ampliﬁed an adjacent region of DNA from the TBM, we did
ﬁnd at least one splice variant and 12 identical clones. Interestingly,
this relatively rare splice variant (corresponding to NCBI accession
#XP011538085) is homologous to rSlo(0) (i.e., it does not contain
the insert that renders BK channels sensitive to unoprostone). There
has been some suggestion that some individuals do not respond to
unoprostone [4,31] and that at least some of the nonresponsiveness is
genetically based [1]. Obviously, the majority of the DNA in our
TBM sample encodes unoprostone-sensitive BK channels. The origin of
the RNA is somewhat obscure, but probably represents RNA from
primary cultures of a single patient as previously described [5,6,30].
If the rate of ﬁnding the one different clone reﬂects the rate of nonre-
sponders, then approximately 8.3 ± 7.9% of patients will be non re-
sponders and we would have to examine RNA from at least 35
separate eyes to identify with 5% conﬁdence a TBMwithout the respon-
sive insert. That only 4 out of 15 published sequences have the respon-
sive sequence suggest that using unoprostone in tissues other than TBM
my require testing the genetic variability in BK channels to assess likely
efﬁcacy.
Our results have important implications for the use of unoprostone
to activate BK channels. Channel activation will be limited if intracellu-
lar Ca2+ is not elevated. For example, themore strongly a trabecular cell
is depolarized allowing calcium entry, the stronger the effect of
unoprostone. This implies that unoprostone will “select” only those
cells that can be most affected and that these cells are the cells that
are preventing ﬂuid loss and inducing high intraocular pressures. It
also implies that if cells are not depolarized (with high intracellular cal-
cium) that there will be only modest effects of unoprostone. This could
lead to misinterpretation of results from clinical trials.
More fascinating is the possibility of the results suggesting other
uses for unoprostone (or other related prostones). Ordinarily, depolari-
zation of nerve cells accompanied by increased calcium entry is
prevented from positive feedback by the activation BK channels with
subsequent hyperpolarization. However, in several CNS disorders that
are characterized by having inappropriate depolarization accompanied
by increased calcium entry (epilepsy, ischemic stroke, Parkinson's dis-
ease), normal activity of BK channels is not sufﬁcient to prevent
excitotoxicity. A BK channel activator seems like a logical therapeutic
choice as one mode of treatment (particularly given the prostones
anti-inﬂammatory action [22]). However, it would be critical to know
the BK splice variant present in the target neurons since both sensitive
and insensitive variants are present in the CNS. However, given the
datawe present in this report (especially Figs. 2 and 3), the calciumcon-
centrations in ischemic neurons should be sufﬁcient to allow a strong
potentiation of BK channel activity in CNS neurons and hyperpolariza-
tion of the ischemic neurons, reducing excitatory amino acid release,
and reducing ischemic calcium entry.Conﬂict of interest
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